1. Home
  2. BYND vs DCTH Comparison

BYND vs DCTH Comparison

Compare BYND & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Meat Inc.

BYND

Beyond Meat Inc.

HOLD

Current Price

$0.79

Market Cap

346.2M

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$9.08

Market Cap

323.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BYND
DCTH
Founded
2009
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.2M
323.1M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
BYND
DCTH
Price
$0.79
$9.08
Analyst Decision
Sell
Strong Buy
Analyst Count
7
4
Target Price
$1.70
$22.00
AVG Volume (30 Days)
30.2M
510.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
53.80
107.53
EPS
N/A
0.07
Revenue
$326,452,000.00
N/A
Revenue This Year
N/A
$29.20
Revenue Next Year
N/A
$29.54
P/E Ratio
N/A
$130.29
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$8.12
52 Week High
$7.69
$18.23

Technical Indicators

Market Signals
Indicator
BYND
DCTH
Relative Strength Index (RSI) 48.49 43.97
Support Level $0.67 $8.90
Resistance Level $0.82 $10.39
Average True Range (ATR) 0.08 0.40
MACD 0.01 -0.03
Stochastic Oscillator 28.25 33.14

Price Performance

Historical Comparison
BYND
DCTH

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: